Why the study?
Does double antiplatelet therapy affect shear-dependent blood activation and clot formation in an ex-vivo model?
Population
28 patients
Comparison
Ex-vivo blood testing using a cone-on-plate… vs Patients free from major antiplatelet agents vs…
Design
Preclinical
Authors
Loading...
Model may enable activator-free shear testing in vitro; leaves open validation in larger cohorts before any clinical use.
Does double antiplatelet therapy affect shear-dependent blood activation and clot formation in an ex-vivo model?
An ex-vivo model of shear-dependent blood activation demonstrates that double antiplatelet therapy significantly delays clot formation and reduces clot viscosity without requiring artificial activators.
Ranucci et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: